Establishment Labs Holdings Inc. (ESTA)
Establishment Labs Holdings Inc.
Building B15 and 25
Coyol Free Zone
Alajuela
Costa Rica
506 2434 2400
https://www.establishmentlabs.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 908
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Juan Jose Chacon Quiros | Founder, CEO & Executive Director | 1.09M | N/D | 1973 |
| Mr. Rajbir Singh Denhoy | Chief Financial Officer | 533.2k | N/D | 1971 |
| Mr. S. Ross Mansbach | General Counsel, Chief Compliance Officer & Chief Human Resources Officer | 509.76k | N/D | 1967 |
| Mr. Roberto de Mezerville | Chief Technology Officer | N/D | N/D | 1981 |
| Mr. Salvador Santos Dada | Head of Special Projects | 468.62k | N/D | 1982 |
| Ms. Rosalyn Cole d'Incelli | SVP of Global Clinical, Medical & US Regulatory Affairs | N/D | N/D | N/D |
| Ms. Elizabeth Panzica Newman | VP & Head of U.S Business Unit | N/D | N/D | N/D |
| Mr. Ivan Bilic | Senior Vice President of Commercial Operations - OUS | N/D | N/D | N/D |
| Ms. Neeta Toprani | Corporate Secretary | N/D | N/D | N/D |
Descripción
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Gestión corporativa
La calificación ISS Governance QuickScore de Establishment Labs Holdings Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
